| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.011 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |